The growing use of counterfeited Tramadol in Africa represents a serious health crisis but criminalising its use would lead to criminalising people in pain.
The criminalisation of drug use disproportionately affects racial minorities and marginalised communities. A regulation framework for cannabis should take this into account to avoid recreating these same inequities.
As Western Europe's harm reduction programs became mainstream and nationalised, the grass-root activism that created the movement is fading and progress is slowed down.
